Similar Articles
Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study
Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee
DOI: 10.46497/ArchRheumatol.2022.9140
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi
DOI: 10.46497/ArchRheumatol.2022.9217
Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
Ferhat Demir, Eda Gürler, Betül Sözeri
DOI: 10.46497/ArchRheumatol.2022.8998
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec
DOI: 10.46497/ArchRheumatol.2022.9255
MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis
Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao
DOI: 10.46497/ArchRheumatol.2022.9168
The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients
Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed
DOI: 10.46497/ArchRheumatol.2022.9307
Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus
Yuewu Tang, Yi Luo
DOI: 10.46497/ArchRheumatol.2022.9167
Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?
Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin
DOI: 10.46497/ArchRheumatol.2022.9366
Association of pain and clinical factors on disability and quality of life in systemic sclerosis: A cross-sectional study from Turkish League Against Rheumatism Network
Remzi Çevik, Serda Em, Kemal Nas, Murat Toprak, Gizem Cengiz, Mustafa Çalış, İlhan Sezer, Ayşe Ünal Enginar, Pınar Bora Karslı, Sinem Sağ, Betül Sargın, Meltem Alkan Melikoğlu, Yıldıray Aydın, Mehmet Tuncay Duruöz, Halise Hande Gezer, Hilal Ecesoy
DOI: 10.46497/ArchRheumatol.2023.9243
Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study
Kemal Nas, Ertuğrul Güçlü, Yaşar Keskin, Gamze Dilek, Mehtap Kalçık Unan, Nurselin Can, İbrahim Tekeoğlu, Ayhan Kamanlı
DOI: 10.46497/ArchRheumatol.2023.9289
Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up
Rasha N Yousef, Abeer Ramadan, Eman Awadallah, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E.Behiry, Asmaa Ali, Hesham Gamal El Dine
DOI: 10.46497/ArchRheumatol.2023.9448
Patients with inflammatory myopathies overlapping with systemic sclerosis: A Brazilian-Japanese bicentric study
Jucier Gonçalves Júnior, Naoki Mugii, Pleiades Tiharu Inaoka, Renata Miossi, Fernando Henrique Carlos De Souza, João Calvino Soares De Oliveira, Fujiko Someya, Yasuhito Hamaguchi, Takashi Matsushita, Percival Degrava Sampaio-Barros, Samuel Katsuyuki Shinjo
DOI: 10.46497/ArchRheumatol.2023.9597
Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein
DOI: 10.46497/ArchRheumatol.2023.9638
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636
Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity
Maryam Rezazadeh, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, Zahra Mirfeizi, Mahmoud Mahmoudi, Negar Morovatdar, Kamila Hashemzadeh
DOI: 10.46497/ArchRheumatol.2023.9549
Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies
Sherif Gamal, Hanaa Rady, Nesreen Sobhy, Ibrahem Siam, Ahmed Soliman, Fatema Elgengehy
DOI: 10.46497/ArchRheumatol.2023.9860
Males and females with scleroderma: A comparative study in a Brazilian sample
Matheus Costa, Igor Jorge, Patricia Martin, Renato Nisihara, Thelma Skare
DOI: 10.46497/ArchRheumatol.2023.10011
The evaluation of tibial nerve using shear-wave elastography and ultrasound in patients with systemic sclerosis: A cross-sectional study
Serdar Kaymaz, Murat Yiğit, Furkan Ufuk, Burak Sarılar, Uğur Karasu, Veli Çobankara, Nuran Sabir, Hakan Alkan
DOI: 10.46497/ArchRheumatol.2023.9835
The effects of Lactobacillus delbrueckii and Lactobacillus rhamnosus on cytokines and their related molecules: An ex vivo study on patients with systemic lupus erythematosus
Atefeh Alaei, Mahmoud Mahmoudi, Maryam Sahebari, Zohreh Vahidi, Nafiseh Tabasi, Maryam Rastin
DOI: 10.46497/ArchRheumatol.2023.9941
Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus
Lingyan He, Mingming Yan, Rui Wen, Jiali Li
DOI: 10.46497/ArchRheumatol.2024.9977